Skip to main content
. 2024 Apr 29;15(2):641–667. doi: 10.21037/jgo-23-956

Figure 1.

Figure 1

Expression status and prognostic value of NXPH4 in pan-cancer. (A,B) Expression of NXPH4 in different tumor tissues and normal tissues according to the TCGA database. (C) Prognostic analysis of NXPH4 expression levels in different human cancers. *, P<0.05; **, P<0.01; ***, P<0.001; ns, no significance. NXPH4, neurexophilin 4; TPM, transcripts per million; ACC, adrenocortical carcinoma; HR, hazard ratio; BLCA, bladder urothelial carcinoma; BRCA, breast invasive carcinoma; COAD, colon adenocarcinoma; KIRP, kidney renal papillary cell carcinoma; LIHC, liver hepatocellular carcinoma; READ, rectum adenocarcinoma; UCEC, uterine corpus endometrial carcinoma; UVM, uveal melanoma; TCGA, The Cancer Genome Atlas.